EPISODE · Jul 1, 2025 · 6 MIN
Labile Copper Test Enhances Evaluation for Wilson's Disease: Joshua Bornhorst, Ph.D.
from Answers from the Lab · host Mayo Clinic Laboratories
Joshua Bornhorst, Ph.D., explains how Mayo Clinic Laboratories' labile copper assay (Mayo ID: LBCS) improves upon standard blood tests for Wilson's disease. The new test measures not just overall copper but also the fraction of copper that is bioavailable, or labile bound.(00:32) Can you tell us a little bit about yourself and your background? (01:33) Could you give us a brief overview of this assay? (02:47) Which patients should have this testing, and when should it be performed? (03:48) How would the results be used in patient care?
NOW PLAYING
Labile Copper Test Enhances Evaluation for Wilson's Disease: Joshua Bornhorst, Ph.D.
No transcript for this episode yet
Similar Episodes
No similar episodes found.